Time to treat the climate and nature crisis as one indivisible global health emergency
Immunopharmacol Immunotoxicol. 2023 Oct 27:1-4. doi: 10.1080/08923973.2023.2276510. Online ahead of print.NO ABSTRACTPMID:37889283 | DOI:10.1080/08923973.2023.2276510 (Source: Immunopharmacology and Immunotoxicology)
Source: Immunopharmacology and Immunotoxicology - October 27, 2023 Category: Allergy & Immunology Authors: Kamran Abbasi Parveen Ali Virginia Barbour Thomas Benfield Kirsten Bibbins-Domingo Gregory E Erhabor Stephen Hancocks Richard Horton Laurie Laybourn-Langton Robert Mash Peush Sahni Wadeia Mohammad Sharief Paul Yonga Chris Zielinski Source Type: research

Prediction of prognostic and immune therapy response in lung adenocarcinoma based on MHC-I-related genes
Conclusion: Overall, the study revealed MHC-I-related molecular prognostic biomarkers as robust indicators for LUAD prognosis and immune therapy response.PMID:37728543 | DOI:10.1080/08923973.2023.2261146 (Source: Immunopharmacology and Immunotoxicology)
Source: Immunopharmacology and Immunotoxicology - September 20, 2023 Category: Allergy & Immunology Authors: Hangdi Xu Yanjie Hu Xiuming Peng Enguo Chen Source Type: research